Learn why genetic testing is vital for ATTR-CM diagnosis, how it identifies hereditary risks for family members, and the ...

Allogene announced the futility analysis, which was triggered by the protocol-defined data cutoff of the 24 th patient completing Day 45 minimal residual disease (“MRD”) assessment, showed that 58.3% ...

A study published April 10 in The Lancet reports that the anti-PD-1 immunotherapy pembrolizumab (brand name Keytruda) ...

At a first meeting on pediatric gene and cell therapy trials, participants discussed when enrolling children before adults is ethical and when to wait.

NIH-funded UT team and colleagues from Metagenomi Thereapeutics discovered highly efficient enzyme could enable targeted gene editing within the human body.

Wellness influencers tout the therapy's power for everything from rejuvenating skin and hair to boosting longevity. Devices sold for at-home use abound. We look at the evidence behind the hype.